Novel partners with colistin to increase its in vivo therapeutic effectiveness and prevent the occurrence of colistin resistance in NDM- and MCR-co-producing Escherichia coli in a murine infection model. (2019)
Attributed to:
Determining the clinical and environmental impact, burden and cost of Extensively Drug Resistant Enterobacteriaceae in China (DETER-XDRE-CHINA-HUB)
funded by
Newton Fund
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/jac/dky413
PubMed Identifier: 30346547
Publication URI: http://europepmc.org/abstract/MED/30346547
Type: Journal Article/Review
Volume: 74
Parent Publication: The Journal of antimicrobial chemotherapy
Issue: 1
ISSN: 0305-7453